Writing
I write the Techbio<>Biotech letter about topics at the intersection of software, machine learning, and biology addressed toward a semi-technical audience to provide intuition for complex trends and technologies. Subscribers include Fortune 100 executives, VCs, and leading researchers.
Other Collected Communications
I have written and spoken on topics related to drug discovery, next generation therapeutics, AI and machine learning and other topics with leading journalists and industry leaders. Below are a selection of articles and venues.
